Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome
出版年份 2021 全文链接
标题
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome
作者
关键词
-
出版物
npj Biofilms and Microbiomes
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-16
DOI
10.1038/s41522-021-00205-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
- (2020) Min Wu et al. Frontiers in Pharmacology
- Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(/–) mice
- (2020) Xiaolei Ma et al. Acta Pharmaceutica Sinica B
- The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery
- (2019) Yu Du et al. Expert Opinion on Drug Discovery
- The intestinal microbiota regulates host cholesterol homeostasis
- (2019) Tiphaine Le Roy et al. BMC BIOLOGY
- Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice
- (2019) Yu Du et al. BRITISH JOURNAL OF PHARMACOLOGY
- Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice
- (2019) Amar Bahadur Singh et al. Scientific Reports
- Impact of Gut Microbiota and Diet on the Development of Atherosclerosis inApoe−/−Mice
- (2018) Annika Lindskog Jonsson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe −/− mice
- (2018) Lin Zhu et al. ATHEROSCLEROSIS
- RELATIONSHIP BETWEEN STATIN USE AND TRIMETHYLAMINE N-OXIDE IN CARDIOVASCULAR RISK ASSESSMENT
- (2018) Daniel Y. Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
- (2018) Liping Zhao et al. SCIENCE
- Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
- (2018) Ru Feng et al. Frontiers in Pharmacology
- The Anti-inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs
- (2018) Meng Li et al. Frontiers in Pharmacology
- Diet, Microbes, and Murine Atherosclerosis
- (2018) Godfrey S. Getz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice
- (2018) Yafei Shi et al. BIOMEDICINE & PHARMACOTHERAPY
- Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
- (2018) Adam B. Roberts et al. NATURE MEDICINE
- Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria
- (2018) Marina Orman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism
- (2017) Yan Wang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Uncovering the trimethylamine-producing bacteria of the human gut microbiota
- (2017) Silke Rath et al. Microbiome
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
- (2016) Weifei Zhu et al. CELL
- Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
- (2016) Runbin Sun et al. MOLECULAR PHARMACOLOGY
- Role of gut microbiota in atherosclerosis
- (2016) Annika Lindskog Jonsson et al. Nature Reviews Cardiology
- microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator
- (2015) Huajun Jiang et al. ATHEROSCLEROSIS
- Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
- (2015) Zeneng Wang et al. CELL
- TMAO: A small molecule of great expectations
- (2015) Marcin Ufnal et al. NUTRITION
- Small molecules from the human microbiota
- (2015) M. S. Donia et al. SCIENCE
- Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide
- (2015) Kymberleigh A. Romano et al. mBio
- Transforming berberine into its intestine-absorbable form by the gut microbiota
- (2015) Ru Feng et al. Scientific Reports
- A Healthy Diet Is Associated with Less Endothelial Dysfunction and Less Low-Grade Inflammation over a 7-Year Period in Adults at Risk of Cardiovascular Disease
- (2015) Bas CT van Bussel et al. JOURNAL OF NUTRITION
- Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation
- (2014) Jill C. Gregory et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The contributory role of gut microbiota in cardiovascular disease
- (2014) W.H. Wilson Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of Sodium Butyrate as an Alternative to Dietary Fiber: Effects on the Embryonic Development and Anti-Oxidative Capacity of Rats
- (2014) Yan Lin et al. PLoS One
- Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
- (2014) Shinobu Miyazaki-Anzai et al. PLoS One
- Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
- (2014) Y. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
- (2013) Anita Wichmann et al. Cell Host & Microbe
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
- (2013) Brian J. Bennett et al. Cell Metabolism
- Effects of berberine on lipid profile in subjects with low cardiovascular risk
- (2013) Giuseppe Derosa et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Richness of human gut microbiome correlates with metabolic markers
- (2013) Emmanuelle Le Chatelier et al. NATURE
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
- (2013) W.H. Wilson Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
- (2013) Xiang-Shan Tan et al. PLoS One
- Targeting the Human Genome–Microbiome Axis for Drug Discovery: Inspirations from Global Systems Biology and Traditional Chinese Medicine
- (2012) Liping Zhao et al. JOURNAL OF PROTEOME RESEARCH
- Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
- (2012) Xu Zhang et al. PLoS One
- Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
- (2012) S. Craciun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Influence of 9p21.3 Genetic Variants on Clinical and Angiographic Outcomes in Early-Onset Myocardial Infarction
- (2011) Diego Ardissino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
- (2010) Y.-T. Liu et al. DRUG METABOLISM AND DISPOSITION
- The development of intestinal lymphoid tissues at the interface of self and microbiota
- (2009) G Eberl et al. Mucosal Immunology
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started